is this 1-pg chat still open?, page-388

The success will come down to the MC that it trades at.

High cost to establish M M growing facilties, that cost has been met.

Long lead times, that timeframe has been endured by EuroCann.

Legislation is prohibitive , EuroCann has pushed through the hurdles.

Early stage in terms of legislation, so early adopter is a huge positive.

Strong sales, big positive.

Based in Germany, so a friendly progressive jurisdiction.

Market is hungry for MM products

Health pro,s are keen to ramp up the usage, EuroCann has supplies.

Some huge positives and thats just the beginning.



Should trade somewhere between $80 - 120 Mill MC, mainly because it is so unique and there is a large moat currently for such a business.

Makes it very valuable and a take over target for bigger retail/pharmacy companies.